HELP     Sign In
Search

Relevance to Autism

CNVs involving UPF2 were statistically enriched in a cohort of 57.356 patients with neurodevelopmental disorders compared to a cohort of 20,474 controls (deletions, P=0.034805; duplications, P=0.018903). A de novo 2.04 Mb deletion encompassing the UPF2 gene was detected in a female patient from the Developmental Gene Discovery Project (DGDP151) with autism spectrum disorder, intellectual disability, trichotillomania, aggressive behavior, and neuroregression (Nguyen et al., 2013).

Molecular Function

This gene encodes a protein that is part of a post-splicing multiprotein complex involved in both mRNA nuclear export and mRNA surveillance. mRNA surveillance detects exported mRNAs with truncated open reading frames and initiates nonsense-mediated mRNA decay (NMD). When translation ends upstream from the last exon-exon junction, this triggers NMD to degrade mRNAs containing premature stop codons. This protein is located in the perinuclear area. It interacts with translation release factors and the proteins that are functional homologs of yeast Upf1p and Upf3p.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Contribution of copy number variants involving nonsense-mediated mRNA decay pathway genes to neuro-developmental disorders.
ID, DD
ASD
Support
Genome sequencing identifies multiple deleterious variants in autism patients with more severe phenotypes.
ASD
Support
The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies.
DD, ADHD
Support
Large-scale discovery of novel genetic causes of developmental disorders.
Unknown diagnosis
Support
Integrating de novo and inherited variants in 42
ASD
Support
Severe childhood speech disorder: Gene discovery highlights transcriptional dysregulation
DD
Support
UPF2 leads to degradation of dendritically targeted mRNAs to regulate synaptic plasticity and cognitive function.
Support
Whole genome sequencing and variant discovery in the ASPIRE autism spectrum disorder cohort.
ASD
Recent Recommendation
Inhibition of Upf2-Dependent Nonsense-Mediated Decay Leads to Behavioral and Neurophysiological Abnormalities by Activating the Immune Response.
Speech and language disorders
ASD
Recent Recommendation
A common molecular signature in ASD gene expression: following Root 66 to autism.

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN518R001 
 copy_number_loss 
  
  
 De novo 
  
 Unknown 
 GEN518R002 
 frameshift_variant 
 AC>A 
  
 De novo 
  
 Unknown 
 GEN518R003 
 translocation 
  
  
 De novo 
  
  
 GEN518R004 
 missense_variant 
 c.-15G>T 
  
 De novo 
  
 Simplex 
 GEN518R005 
 missense_variant 
 c.1958G>A 
 p.Arg653Gln 
 Unknown 
  
 Multiplex 
 GEN518R006 
 frameshift_variant 
 c.1940del 
 p.Asp647ValfsTer24 
 De novo 
  
  
 GEN518R007 
 frameshift_variant 
 c.986del 
 p.Ser329MetfsTer8 
 De novo 
  
  
 GEN518R008 
 copy_number_loss 
  
  
 De novo 
  
  
 GEN518R009 
 frameshift_variant 
 c.1940del 
 p.Asp647ValfsTer24 
 De novo 
  
 Simplex 
 GEN518R010 
 missense_variant 
 c.3517A>T 
 p.Met1173Leu 
 De novo 
  
  
 GEN518R011 
 splice_region_variant 
 c.3035-3A>C 
  
 De novo 
  
 Simplex 
 GEN518R012 
 synonymous_variant 
 c.2289C>T 
 p.Thr763%3D 
 De novo 
  
  
 GEN518R013 
 frameshift_variant 
 c.1095dup 
 p.His366ThrfsTer13 
 De novo 
  
  

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
10
Deletion-Duplication
 14
 
10
Deletion-Duplication
 1
 
10
Deletion
 1
 
10
Deletion
 1
 
10
Deletion
 4
 
10
Duplication
 2
 
10
Duplication
 1
 
10
Duplication
 1
 
10
Duplication
 1
 
10
Deletion
 3
 
10
Deletion-Duplication
 3
 

Model Summary

Mice lacking Upf2 in the forebrain show impaired nonsense mediated decay, impaired cognitive flexibility, memory deficits, abnormal long-term potentiation, social and communication deficits, increased expression of immune genes and brain inflammation. Chronic treatment with two FDA-approved anti-inflammatory drugs, CyP and Mino, reduced brain inflammation, restored LTP and long-term memory, and reversed social and communication deficits.

References

Type
Title
Author, Year
Primary
Inhibition of Upf2-Dependent Nonsense-Mediated Decay Leads to Behavioral and Neurophysiological Abnormalities by Activating the Immune Response.

M_UPF2_1_CKO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Mice with conditional deletion of Upf2 in the forebrain with loxp sites flanking exons 2, containing the initiating ATG, and 3 (Weischenfeldt et al., 2008) through CamKII-Cre (forebrain Cre driver, JAX: 027400) mediated excision. Control littermates included Upf2^wt/wt, Upf2^wt/wt; Camk2a-Cre mice, and Upf2^loxP/loxP mice.
Allele Type: Conditional knockout
Strain of Origin:
Genetic Background: C57BL/6J
ES Cell Line:
Mutant ES Cell Line:
Model Source: Weischenfeldt et al., 2008; Dragatsis and Zeitlin, 2000

M_UPF2_1_CKO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Synaptic plasticity: hippocampal ltp1
Decreased
Description: Mutants show decrease in ltp at schaffer collateral-ca1 synapses in the hippocampus.
Exp Paradigm: NA
 Field potential recordings
 3 months
Stereotypy1
Decreased
Description: Mutants show fewer spontaneous alterations indicating behavioral inflexibility.
Exp Paradigm: NA
 T-maze test
 3 months
Social interaction1
Decreased
Description: Mutants spend less time in direct social interaction.
Exp Paradigm: NA
 Reciprocal social interaction test
 3 months
Social memory1
Decreased
Description: Mutants show decrease in time spent with an unfamiliar over a familiar mouse.
Exp Paradigm: NA
 Three-chamber social approach test
 3 months
Ultrasonic vocalization: interaction induced: same sex stimulus1
Decreased
Description: Mutants emit fewer interaction-induced usvs in same-sex adult female pairs. mutants show more complex and louder call patterns.
Exp Paradigm: NA
 Monitoring ultrasonic vocalizations
 3 months
Cytokine levels: pro-inflammatory1
Increased
Description: Mutants show increase in the pro-inflammatory cytokine rantes and the t cell chemoattractants ip-10 and mig only in the forebrain.
Exp Paradigm: NA
 Flow cytometric analysis
 3 months
Adaptive immune response: b cells1
Increased
Description: Mutants show increase in the total number of immune cells in the brain including cd11b, b220 positive b cells. mutants show no change in immune cells in the spleen.
Exp Paradigm: NA
 Flow cytometric analysis
 3 months
Cns inflammation1
Increased
Description: Mutants show increase in the total number of immune cells in the brain.
Exp Paradigm: NA
 Flow cytometric analysis
 1, 3, 5 months
Microgliosis1
Increased
Description: Mutants show increase in iba1 in the hippocampus and neocortex.
Exp Paradigm: NA
 Immunohistochemistry
 3 months
Astrogliosis1
Increased
Description: Mutants show increase in gfap in the hippocampus and neocortex.
Exp Paradigm: NA
 Immunohistochemistry
 3 months
Innate immune response1
Increased
Description: Mutants show increase in the total number of immune cells in the brain including ly6g positive neutrophils. mutants show no change in immune cells in the spleen.
Exp Paradigm: NA
 Flow cytometric analysis
 3 months
Adaptive immune response: t cells1
Increased
Description: Mutants show increase in the total number of immune cells in the brain including cd3 positive t cells. mutants show no change in immune cells in the spleen. mutant but not control brain lysates increase control t cell proliferation.
Exp Paradigm: NA
 Flow cytometric analysis
 3 months
Cued or contextual fear conditioning: memory of context1
Decreased
Description: Mutants show decrease in freezing in response to context at 3 months but not at 1 month.
Exp Paradigm: NA
 Fear conditioning test
 3 months, 1 month
Spatial working memory1
Decreased
Description: Mutants took longer to find the submerged platform.
Exp Paradigm: NA
 Morris water maze test
 3 months
Spatial reference memory1
Decreased
Description: Mutants failed to remember the location of the platform during probe trial.
Exp Paradigm: NA
 Morris water maze test
 3 months
Targeted expression1
Decreased
Description: Mutants show decrease in upf2 transcript levels in the hippocampus and cerebral cortex but not in the cerebellum. mutants show decrease in upf2 transcript at 3 months but not at 1 month in the hippocampus.
Exp Paradigm: NA
 Quantitative pcr (qrt-pcr)
 3 months, 1 month
Gene expression1
Decreased
Description: Mutants show nmd mrna substrates atf4, gadd45b, pdrg1, cars, ddit3, and rassf1 were all significantly upregulated in the hippocampus and cortex but not in the cerebellum. mutants show no change in transcript levels of non-nmd targets gapdh, vsp4a, and srp72 in the cortex and hippocampus. mutants show increased expression of approximately 300 genes at steady state including immune related genes.
Exp Paradigm: NA
 Quantitative pcr (qrt-pcr)
 3 months
Spatial learning1
 No change
 Morris water maze test
 3 months
Swimming ability1
 No change
 Morris water maze test
 3 months
Epsp-spike relationship1
 No change
 Field potential recordings
 3 months
Presynaptic function: paired-pulse facilitation1
 No change
 Field potential recordings
 3 months
Social approach1
 No change
 Three-chamber social approach test
 3 months
 Not Reported: Circadian sleep/wake cycle, Developmental profile, Emotion, Maternal behavior, Neuroanatomy / ultrastructure / cytoarchitecture, Physiological parameters, Seizure, Sensory

 

No Interactions Available
HELP
Copyright © 2017 MindSpec, Inc.